Epalinges, Switzerland · Founded 2015 · Privately Held (backing)
Developer of a suction cervical stabilizer designed to reduce pain and eliminate the risk of lesions and bleeding in women for gynecological purposes. Aspivix is based in Epalinges, Switzerland and was founded in 2015. Its last known valuation is $28.4 million. It has raised $20.1 million.
Last price · $/share
—
Implied valuation
$28.4M
Total raised
$20.1M
Last round
—
Cap table — not yet on record
Aspivix's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Aspivix with a free account
·The complete investor list: 11 names
·Watch Aspivix: the Monday email on marks, rounds and moves
